In conclusion, we confirmed that Gyp can significantly reduce the lipid content in the liver and serum, reduce serum ALT and AST activities, improve insulin resistance and ameliorate pathological changes in liver tissues. The gene discussed is GPT; the disease is Insulin resistance.